Meeting
2015 Genitourinary Cancers Symposium
Prospective phase 1 study assessing feasibility of IMRT and IGART to deliver simultaneous integrated high-dose tumor boost (up to 70 Gy) for the radical treatment of localized muscle-invasive bladder cancer.
Authors
Shaista Hafeez
The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Shaista Hafeez , Karole Warren-Oseni , Helen McNair , Vibeke Hansen , Fiona McDonald , Susan Lalondrelle , Alan Thompson , Pardeep Kumar , Victoria Harris , Melissa Tan , Kabir Mohammed , Karen Thomas , Kelly Jones , David Paul Dearnaley , Alan Horwich , Robert Anthony Huddart
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Clinical Trial Registration Number
NCT01124682
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 307)
DOI
10.1200/jco.2015.33.7_suppl.307
Abstract #
307
Poster Bd #
E18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial.
First Author: Rana R. McKay
Poster
2023 ASCO Annual Meeting
RT-PACE: Phase I/II study of adjuvant whole pelvic hypofractionated radiotherapy for non-metastatic cervical and endometrial cancer.
First Author: Christina H. Son
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Toxicity and efficacy of stereotactic body radiation therapy vs. intensity-modulated radiation therapy for the treatment of locally advanced pancreatic cancer in a phase 3 trial.
First Author: Karyn A. Goodman
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma.
First Author: Mandana Kamgar